199 related articles for article (PubMed ID: 30580105)
41. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
[TBL] [Abstract][Full Text] [Related]
42. [Clinical analysis of pregnancy complicated with severe thrombocytopenia].
Wang DP; Liang MY; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):401-5. PubMed ID: 21029587
[TBL] [Abstract][Full Text] [Related]
43. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
[TBL] [Abstract][Full Text] [Related]
44. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
[TBL] [Abstract][Full Text] [Related]
45. A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
Stanworth SJ; Estcourt LJ; Powter G; Kahan BC; Dyer C; Choo L; Bakrania L; Llewelyn C; Littlewood T; Soutar R; Norfolk D; Copplestone A; Smith N; Kerr P; Jones G; Raj K; Westerman DA; Szer J; Jackson N; Bardy PG; Plews D; Lyons S; Bielby L; Wood EM; Murphy MF;
N Engl J Med; 2013 May; 368(19):1771-80. PubMed ID: 23656642
[TBL] [Abstract][Full Text] [Related]
46. How do we approach thrombocytopenia in critically ill patients?
Thachil J; Warkentin TE
Br J Haematol; 2017 Apr; 177(1):27-38. PubMed ID: 27982413
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
[TBL] [Abstract][Full Text] [Related]
48. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
49. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.
Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ
Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995
[TBL] [Abstract][Full Text] [Related]
50. Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.
Platzbecker U; Wong RS; Verma A; Abboud C; Araujo S; Chiou TJ; Feigert J; Yeh SP; Götze K; Gorin NC; Greenberg P; Kambhampati S; Kim YJ; Lee JH; Lyons R; Ruggeri M; Santini V; Cheng G; Jang JH; Chen CY; Johnson B; Bennett J; Mannino F; Kamel YM; Stone N; Dougherty S; Chan G; Giagounidis A
Lancet Haematol; 2015 Oct; 2(10):e417-26. PubMed ID: 26686043
[TBL] [Abstract][Full Text] [Related]
51. Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial.
van de Weerdt EK; Biemond BJ; Zeerleder SS; van Lienden KP; Binnekade JM; Vlaar APJ;
Trials; 2018 Feb; 19(1):127. PubMed ID: 29463280
[TBL] [Abstract][Full Text] [Related]
52. CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia.
Garcia-Manero G; Scott BL; Cogle CR; Boyd TE; Kambhampati S; Hetzer J; Dong Q; Kumar K; Ukrainskyj SM; Beach CL; Skikne BS
Leuk Res; 2018 Sep; 72():79-85. PubMed ID: 30114559
[TBL] [Abstract][Full Text] [Related]
53. Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndrome.
Montero AJ; Estrov Z; Freireich EJ; Khouri IF; Koller CA; Kurzrock R
Leuk Lymphoma; 2006 Oct; 47(10):2049-54. PubMed ID: 17071475
[TBL] [Abstract][Full Text] [Related]
54. Preoperative platelet transfusions: A retrospective review of pediatric patients with thrombocytopenia, 2011-2016.
Muegge J; de Warren T; Saltzman D; Hess D
J Pediatr Surg; 2021 Sep; 56(9):1657-1660. PubMed ID: 34074485
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial.
Eghbali A; Melikof L; Taherahmadi H; Bagheri B
Haemophilia; 2016 Sep; 22(5):e423-6. PubMed ID: 27478149
[TBL] [Abstract][Full Text] [Related]
56. Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia.
van Baarle FLF; van de Weerdt EK; van der Velden WJFM; Ruiterkamp RA; Tuinman PR; Ypma PF; van den Bergh WM; Demandt AMP; Kerver ED; Jansen AJG; Westerweel PE; Arbous SM; Determann RM; van Mook WNKA; Koeman M; Mäkelburg ABU; van Lienden KP; Binnekade JM; Biemond BJ; Vlaar APJ
N Engl J Med; 2023 May; 388(21):1956-1965. PubMed ID: 37224197
[TBL] [Abstract][Full Text] [Related]
57. Towards Developing a Scoring System for Febrile Thrombocytopenia.
Kshirsagar P; Chauhan S; Samel D
J Assoc Physicians India; 2016 Feb; 64(2):14-18. PubMed ID: 27730775
[TBL] [Abstract][Full Text] [Related]
58. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
Vamvakas EC; Hitzler WE
Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
[TBL] [Abstract][Full Text] [Related]
59. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
Gubanova MN; Ayupova RF; Zhiburt EB
Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
[TBL] [Abstract][Full Text] [Related]
60. Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU).
Anthon CT; Pène F; Perner A; Azoulay E; Puxty K; Van De Louw A; Barratt-Due A; Chawla S; Castro P; Póvoa P; Coelho L; Metaxa V; Kochanek M; Liebregts T; Kander T; Hästbacka J; Andreasen JB; Péju E; Nielsen LB; Hvas CL; Dufranc E; Canet E; Lundqvist L; Wright CJ; Schmidt J; Uhel F; Ait-Oufella H; Krag M; Cos Badia E; Díaz-Lagares C; Menat S; Voiriot G; Clausen NE; Lorentzen K; Kvåle R; Hildebrandt T; Holten AR; Strand K; Tzalavras A; Bestle MH; Klepstad P; Fernandez S; Vimpere D; Paulino C; Graça C; Lueck C; Juhl CS; Costa C; Bådstøløkken PM; Miranda T; Lêdo LSA; Sousa Torres JC; Granholm A; Møller MH; Russell L;
Intensive Care Med; 2023 Nov; 49(11):1327-1338. PubMed ID: 37812225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
